Alpha-lipoic acid supplements: doses, R-ALA vs ALA, and label wording

Alpha-lipoic acid (ALA) supplement labels usually list somewhere between 30 and 600 mg per serving, but the number that matters is the one used in human trials: 600 mg a day by mouth, tested in adults with diabetic nerve symptoms. R-ALA and plain ALA are two forms of the same molecule, and no label wording lets you skip the arithmetic.

This guide explains the two forms, what the trials actually used, how sales pages describe ALA, and a checklist to compare a label against the research before you buy. It is general information, not medical advice.

What is the difference between R-ALA and ALA on a label?

Alpha-lipoic acid has a "chiral" carbon, which means the molecule exists as two mirror-image versions, called R and S. A label that says plain "alpha-lipoic acid" (also called thioctic acid) usually means a racemic mix, which contains both versions in equal parts. A label that says "R-alpha-lipoic acid" claims the R version only.

The R version is the one the body makes and uses. A 2011 clinical review of ALA describes it as a cofactor for enzymes in the mitochondria, the parts of cells that handle energy. A 2016 laboratory paper on the two forms says its authors had earlier found that the R form is better absorbed by mouth than the S form, and that the difference comes from how the body processes them, not from how they cross the gut lining.

That sounds like a reason to prefer R-only products, and it may be. But it does not tell you how many milligrams of R-only ALA equal the amounts tested in trials, and we did not find a conversion in any source we loaded. Our own review data notes that the diabetic neuropathy trials generally used the standard form, so an R-only label with a different number cannot be lined up against them directly.

What doses did the trials use?

The best-known human research on oral ALA is in adults with diabetes and nerve symptoms in the feet. A 2011 review pulled together five randomized, double-blind, placebo-controlled trials with 1,160 participants in total, run in Germany, Russia and Israel. Four of the five reported significant improvement in symptoms compared with placebo. The review concluded that 600 mg a day by vein for 3 weeks was well tolerated, and that 600 mg a day by mouth for up to 5 weeks could offer benefit without significant side effects.

One of those trials, called SYDNEY 2, tested three oral doses. It enrolled 181 people who took 600, 1,200 or 1,800 mg once a day, or placebo, for 5 weeks. The symptom score fell by 4.9 points (51 percent) in the 600 mg group, 4.5 in the 1,200 mg group and 4.7 in the 1,800 mg group, against 2.9 points (32 percent) with placebo. The authors said 600 mg once daily appeared to give the best balance of benefit and risk, because nausea, vomiting and vertigo rose with the dose.

Three points to keep in mind when you read a sales page:

• The people studied had a diagnosed condition. The trials do not show what the same dose does in people without diabetes or nerve damage.
• The trials were short. Most of the placebo-controlled trials in the review ran 3 to 5 weeks, with one that included a longer oral phase.
• Bigger was not better. Doubling or tripling the dose did not improve the symptom score in SYDNEY 2, but it did raise the share of people reporting side effects.

How do label doses compare with the trial dose?

Supplement labels often sit far below 600 mg. The review notes that dietary supplements typically range from 200 to 600 mg. Here is how a few products we have audited compare, using the amounts as recorded in each review:

A low dose is not automatically pointless, and a high dose is not automatically right for you. The point is that a page which cites a 600 mg trial while selling 30 or 150 mg is borrowing a result it did not test. That gap between the study and the bottle is the main thing our reviews look for.

How do sales pages describe ALA?

Three kinds of wording show up again and again, and none of them replaces a milligram amount.

"Granular," "nano" or "bioavailable" ALA. These describe how the ingredient was processed or marketed. The trials above used standard tablets and capsules, or intravenous doses. A special form may or may not be absorbed differently, and the sales page rarely shows a study on that exact form.

"Antioxidant" and "mitochondrial support" language. ALA is an antioxidant in laboratory terms, and the 2011 review discusses that. But the human evidence it appraises is about nerve symptoms in diabetes, and the trials were short. A phrase like "supports cellular energy" is a general statement, not a tested outcome for the product.

A formula listed by name with no amount. In the United States, FDA's labeling guide says a proprietary blend must be identified as such and must show the total weight of the blend, with the ingredients inside listed in descending order by weight. It does not require an amount for each one. A label that shows only a blend weight cannot tell you whether ALA is 10 mg or 300 mg of it.

The same FDA guide says label approval is not required to distribute a dietary supplement, and FDA's consumer Q&A says the agency generally does not approve supplement claims or labeling before use. So words on the bottle are the company's statements, and it is up to you to check them against the research.

What side effects and cautions come with ALA?

In SYDNEY 2, the share of people reporting side effects was 21 percent with placebo, 27 percent at 600 mg, 43 percent at 1,200 mg and 54 percent at 1,800 mg, according to the 2011 review. The effects reported were nausea, vomiting and vertigo. Only the two higher doses were significantly different from placebo.

The review also notes that absorption from the gut varies, and that taking ALA with food lowers uptake. It says it is usually recommended to take it 30 to 60 minutes before a meal or at least 2 hours after one. That is a statement about how the trials and reviews handled dosing, not an instruction for you.

People with diabetes should be especially careful. In several of the trials, diet, oral diabetes medicine or insulin was part of the entry criteria, so ALA was studied alongside usual care, not as a replacement for medicine or for blood sugar monitoring. Numbness, burning or tingling in the feet also deserves a proper diagnosis, because it can come from several causes. Talk to a doctor or pharmacist before you start ALA, particularly if you take diabetes medicine, have kidney or liver problems, or are pregnant.

Checklist: how to read an ALA label

1. Find the Supplement Facts panel. If the sales page only shows a list of names, note it as a warning sign. See how we review for why we treat missing amounts as a problem.
2. Read the amount per serving, then the servings per day. A label of 300 mg per capsule with 2 capsules a day is 600 mg; the same capsule taken once is 300 mg.
3. Check the form. Plain ALA, R-ALA and "granular" ALA are not interchangeable in the research we could find.
4. Match the amount to a real study. Ask which study, which people, how many weeks, and what was measured.
5. Watch for blends. If ALA sits inside a "complex" with only a total weight, you cannot know its share.
6. Do the price math. Compare the cost per 600 mg, not the cost per bottle. Our ClickBank refund guide explains what to do if the product is not what the page promised.
7. Ask a professional. Bring the label to a doctor or pharmacist, especially if you take any regular medicine.

Where does ALA show up in the products we audit?

ALA is a common ingredient in nerve, blood sugar and energy formulas, and it often appears as one of many ingredients rather than the star. You can browse the energy and wellness category and the blood sugar category to see how different products handle it. RegenVive, for example, is a blood sugar formula that lists ALA at 30 mg next to 14 other ingredients, while Nervala is a two-ingredient nerve formula built around a 600 mg dose. The gap between those two products is the whole lesson of this article.

FAQ

Is R-ALA better than regular ALA?

Laboratory work suggests the R form is better absorbed by mouth than the S form. But the clinical trials we looked at generally used the standard mix, so there is no trial-based dose for R-only products that we could confirm. Compare the milligrams and the form together.

How much alpha-lipoic acid is in most supplements?

The 2011 review says dietary supplements range from about 200 to 600 mg. Products in our reviews go from 30 mg up to 600 mg per serving, so the label amount matters more than the ingredient name.

Does the 600 mg trial dose apply to everyone?

No. The trials studied adults with diabetes and nerve symptoms, mostly for 3 to 5 weeks. They do not show what 600 mg does in other people or over longer periods.

Should I take ALA with food?

The review says food lowers absorption and mentions taking it before or well after meals. If you have a health condition or take medicine, ask your doctor or pharmacist how to take it.